cannabinoids

Clearing the Smoke on Cannabis and Cannabinoids: Medical Use of Cannabis and Cannabinoids

Report

29 May 2024

The report, "Clearing the Smoke on Cannabis: Medical Use of Cannabis and Cannabinoids 2024 Update," examines the medical use of cannabis and cannabinoids, emphasizing their effects, efficacy, and the need for more rigorous research. Key...

Early exposure to cannabis and long-lasting consequences in the brain

ISSUP Webinar

23 May 2023

ISSUP Italy are pleased to present their Webinar on How early exposure to cannabis misshapes the brain and exerts long-lived effects.

Early exposure to cannabis and long-lasting consequences in the brain

23 May 2023

Rome

Italy

ISSUP Italy would invite you to their upcoming Webinar on How early exposure to cannabis misshapes the brain and exerts long-lived effects.

Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

Scientific article

8 October 2022

Introduction There is increasing interest and evidence for the use of cannabinoid medications in the treatment of cannabis use disorder, but little examination of the correlates of successful treatment. This paper is a secondary analysis of...

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019

Scientific article

12 January 2022

Abstract Objective Cannabis legalization in many jurisdictions worldwide has raised concerns that such legislation might increase the burden of transient and persistent psychotic illnesses in society. Our study aimed to address this issue...

New Psychoactive Substances: What Are Synthetic Cannabinoids, Their Mechanisms of Action, and Health Risks?

7 July 2022

Washington DC

United States

Thursday, July 7, 2022 10:00 AM Eastern Time (Washington, DC time)

The presenters will discuss synthetic cannabinoids' action mechanisms and health risks in this webinar. Spanish - English interpretation will be available. No certificates of attendance will be offered.

Presenters

The Synaptic Interactions of Alcohol and the Endogenous Cannabinoid System

Scientific article

27 January 2022

ABSTRACT PURPOSE: A growing body of evidence has implicated the endocannabinoid (eCB) system in the acute, chronic, and withdrawal effects of alcohol/ethanol on synaptic function. These eCB-mediated synaptic effects may contribute to the...

Variation in Cannabinoid Metabolites Present in the Urine of Adults Using Medical Cannabis Products in Massachusetts

Scientific article

12 April 2021

The findings of this cohort study are consistent with those of a study of cannabis products purchased in California and Washington, in which more than one-half of products were incorrectly labeled. These findings indicate that adults using...

Cannabinoid Exposure in Rat Adolescence Reprograms the Initial Behavioral, Molecular, and Epigenetic Response to Cocaine

Scientific article

20 April 2020

Significance The endocannabinoid system has a modulatory role in brain reward and cognitive processes. It has been hypothesized that repeated interference with endocannabinoid signaling (e.g., through abuse of cannabis or synthetic...

25th NIDA International Forum

19 June 2020

Hollywood, Florida

United States

The National Institute on